MSE MEDICAL UK LTD

MSE MEDICAL UK LTD - Company Information

2022-01-012022-12-312022-12-31false12417776MSE MEDICAL UK LTD2023-03-2047749iso4217:GBPxbrli:pure124177762022-01-01124177762022-12-31124177762022-01-012022-12-31124177762021-02-01124177762021-12-31124177762021-02-012021-12-3112417776bus:SmallEntities2022-01-012022-12-3112417776bus:AuditExempt-NoAccountantsReport2022-01-012022-12-3112417776bus:AbridgedAccounts2022-01-012022-12-3112417776bus:PrivateLimitedCompanyLtd2022-01-012022-12-3112417776core:WithinOneYear2022-12-3112417776core:AfterOneYear2022-12-3112417776core:WithinOneYear2021-12-3112417776core:AfterOneYear2021-12-3112417776core:ShareCapital2022-12-3112417776core:SharePremium2022-12-3112417776core:RevaluationReserve2022-12-3112417776core:OtherReservesSubtotal2022-12-3112417776core:RetainedEarningsAccumulatedLosses2022-12-3112417776core:ShareCapital2021-12-3112417776core:SharePremium2021-12-3112417776core:RevaluationReserve2021-12-3112417776core:OtherReservesSubtotal2021-12-3112417776core:RetainedEarningsAccumulatedLosses2021-12-3112417776core:LandBuildings2022-12-3112417776core:PlantMachinery2022-12-3112417776core:Vehicles2022-12-3112417776core:FurnitureFittings2022-12-3112417776core:OfficeEquipment2022-12-3112417776core:NetGoodwill2022-12-3112417776core:IntangibleAssetsOtherThanGoodwill2022-12-3112417776core:ListedExchangeTraded2022-12-3112417776core:UnlistedNon-exchangeTraded2022-12-3112417776core:LandBuildings2021-12-3112417776core:PlantMachinery2021-12-3112417776core:Vehicles2021-12-3112417776core:FurnitureFittings2021-12-3112417776core:OfficeEquipment2021-12-3112417776core:NetGoodwill2021-12-3112417776core:IntangibleAssetsOtherThanGoodwill2021-12-3112417776core:ListedExchangeTraded2021-12-3112417776core:UnlistedNon-exchangeTraded2021-12-3112417776core:LandBuildings2022-01-012022-12-3112417776core:PlantMachinery2022-01-012022-12-3112417776core:Vehicles2022-01-012022-12-3112417776core:FurnitureFittings2022-01-012022-12-3112417776core:OfficeEquipment2022-01-012022-12-3112417776core:NetGoodwill2022-01-012022-12-3112417776core:IntangibleAssetsOtherThanGoodwill2022-01-012022-12-3112417776core:ListedExchangeTraded2022-01-012022-12-3112417776core:UnlistedNon-exchangeTraded2022-01-012022-12-3112417776core:MoreThanFiveYears2022-01-012022-12-3112417776core:Non-currentFinancialInstruments2022-12-3112417776core:Non-currentFinancialInstruments2021-12-3112417776dpl:CostSales2022-01-012022-12-3112417776dpl:DistributionCosts2022-01-012022-12-3112417776dpl:AdministrativeExpenses2022-01-012022-12-3112417776core:LandBuildings2022-01-012022-12-3112417776core:PlantMachinery2022-01-012022-12-3112417776core:Vehicles2022-01-012022-12-3112417776core:FurnitureFittings2022-01-012022-12-3112417776core:OfficeEquipment2022-01-012022-12-3112417776core:NetGoodwill2022-01-012022-12-3112417776core:IntangibleAssetsOtherThanGoodwill2022-01-012022-12-3112417776dpl:GroupUndertakings2022-01-012022-12-3112417776dpl:ParticipatingInterests2022-01-012022-12-3112417776dpl:GroupUndertakingscore:ListedExchangeTraded2022-01-012022-12-3112417776core:ListedExchangeTraded2022-01-012022-12-3112417776dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-01-012022-12-3112417776core:UnlistedNon-exchangeTraded2022-01-012022-12-3112417776dpl:CostSales2021-02-012021-12-3112417776dpl:DistributionCosts2021-02-012021-12-3112417776dpl:AdministrativeExpenses2021-02-012021-12-3112417776core:LandBuildings2021-02-012021-12-3112417776core:PlantMachinery2021-02-012021-12-3112417776core:Vehicles2021-02-012021-12-3112417776core:FurnitureFittings2021-02-012021-12-3112417776core:OfficeEquipment2021-02-012021-12-3112417776core:NetGoodwill2021-02-012021-12-3112417776core:IntangibleAssetsOtherThanGoodwill2021-02-012021-12-3112417776dpl:GroupUndertakings2021-02-012021-12-3112417776dpl:ParticipatingInterests2021-02-012021-12-3112417776dpl:GroupUndertakingscore:ListedExchangeTraded2021-02-012021-12-3112417776core:ListedExchangeTraded2021-02-012021-12-3112417776dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-02-012021-12-3112417776core:UnlistedNon-exchangeTraded2021-02-012021-12-3112417776core:NetGoodwill2022-12-3112417776core:IntangibleAssetsOtherThanGoodwill2022-12-3112417776core:LandBuildings2022-12-3112417776core:PlantMachinery2022-12-3112417776core:Vehicles2022-12-3112417776core:FurnitureFittings2022-12-3112417776core:OfficeEquipment2022-12-3112417776core:AfterOneYear2022-12-3112417776core:WithinOneYear2022-12-3112417776core:ListedExchangeTraded2022-12-3112417776core:UnlistedNon-exchangeTraded2022-12-3112417776core:ShareCapital2022-12-3112417776core:SharePremium2022-12-3112417776core:RevaluationReserve2022-12-3112417776core:OtherReservesSubtotal2022-12-3112417776core:RetainedEarningsAccumulatedLosses2022-12-3112417776core:NetGoodwill2021-12-3112417776core:IntangibleAssetsOtherThanGoodwill2021-12-3112417776core:LandBuildings2021-12-3112417776core:PlantMachinery2021-12-3112417776core:Vehicles2021-12-3112417776core:FurnitureFittings2021-12-3112417776core:OfficeEquipment2021-12-3112417776core:AfterOneYear2021-12-3112417776core:WithinOneYear2021-12-3112417776core:ListedExchangeTraded2021-12-3112417776core:UnlistedNon-exchangeTraded2021-12-3112417776core:ShareCapital2021-12-3112417776core:SharePremium2021-12-3112417776core:RevaluationReserve2021-12-3112417776core:OtherReservesSubtotal2021-12-3112417776core:RetainedEarningsAccumulatedLosses2021-12-3112417776core:NetGoodwill2021-02-0112417776core:IntangibleAssetsOtherThanGoodwill2021-02-0112417776core:LandBuildings2021-02-0112417776core:PlantMachinery2021-02-0112417776core:Vehicles2021-02-0112417776core:FurnitureFittings2021-02-0112417776core:OfficeEquipment2021-02-0112417776core:AfterOneYear2021-02-0112417776core:WithinOneYear2021-02-0112417776core:ListedExchangeTraded2021-02-0112417776core:UnlistedNon-exchangeTraded2021-02-0112417776core:ShareCapital2021-02-0112417776core:SharePremium2021-02-0112417776core:RevaluationReserve2021-02-0112417776core:OtherReservesSubtotal2021-02-0112417776core:RetainedEarningsAccumulatedLosses2021-02-0112417776core:AfterOneYear2022-01-012022-12-3112417776core:WithinOneYear2022-01-012022-12-3112417776core:Non-currentFinancialInstrumentscore:CostValuation2022-01-012022-12-3112417776core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-01-012022-12-3112417776core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-01-012022-12-3112417776core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-01-012022-12-3112417776core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-01-012022-12-3112417776core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-01-012022-12-3112417776core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-01-012022-12-3112417776core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-01-012022-12-3112417776core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-01-012022-12-3112417776core:Non-currentFinancialInstrumentscore:CostValuation2022-12-3112417776core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-3112417776core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-3112417776core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-3112417776core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-3112417776core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-3112417776core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-3112417776core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-3112417776core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-3112417776core:Non-currentFinancialInstrumentscore:CostValuation2021-12-3112417776core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2021-12-3112417776core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2021-12-3112417776core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2021-12-3112417776core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2021-12-3112417776core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2021-12-3112417776core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2021-12-3112417776core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2021-12-3112417776core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2021-12-3112417776bus:Director12022-01-012022-12-3112417776bus:Director22022-01-012022-12-31

MSE MEDICAL UK LTD

Registered Number
12417776
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2022

MSE MEDICAL UK LTD

Company Information
for the year from 1 January 2022 to 31 December 2022


Directors	GAETE, Andrew Claudio
	MSE INTERNATIONAL HEALTHCARE SYSTEMS GMBH


Registered Address	Unit C Anchor House School Lane
	Chandler's Ford
	Eastleigh
	SO53 4DY


Registered Number	12417776 (England and Wales)

MSE MEDICAL UK LTD

Balance Sheet as at
31 December 2022

	Notes	2022		2021
		£	£	£	£
Fixed assets
Tangible assets	5		7,718		1,631
Investments			267,518		(164,537)
			275,236		(162,906)
Current assets
Debtors		228,372		54,605
Cash at bank and on hand		33,080		4,569
		261,452		59,174
Creditors amounts falling due within one year	7	(525,026)		(63,653)
Net current assets (liabilities)			(263,574)		(4,479)
Total assets less current liabilities			11,662		(167,385)
Net assets			11,662		(167,385)
Capital and reserves
Called up share capital			100		100
Profit and loss account			11,562		(167,485)
Shareholders' funds			11,662		(167,385)

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The directors have chosen to not file a copy of the company’s profit and loss account.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Board of Directors on 20 March 2023, and are signed on its behalf by:

MSE INTERNATIONAL HEALTHCARE SYSTEMS GMBH
Director
Registered Company No. 12417776

MSE MEDICAL UK LTD

Notes to the Financial Statements
for the year ended 31 December 2022

1.	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	Compliance with applicable reporting framework
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

3.	Accounting policies

	Functional and presentation currency policy
	The financial statements are presented in sterling and this is the functional currency of the company.

	Turnover policy
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods.

	Property, plant and equipment policy
	Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:


		Straight line (years)
	Office Equipment	4

	Revenue recognition policy
	Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer.

	Foreign currency translation and operations policy
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation and operations policy

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Investments policy
	Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

Investments policy

Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

	Employee benefits policy
	Contributions to defined contribution plans are expensed in the period to which they relate.

4.	Employee information


		2022		2021
	Average number of employees during the year	1		0

5.	Property, plant and equipment

		Total
		£
	Cost or valuation
	At 01 January 22	2,253
	Additions	8,474
	At 31 December 22	10,727
	Depreciation and impairment
	At 01 January 22	623
	Charge for year	2,386
	At 31 December 22	3,009
	Net book value
	At 31 December 22	7,718
	At 31 December 21	1,631

6.	Debtors within one year

	2022	2021
	£	£
Trade debtors / trade receivables	159,105	12,407
Other debtors	69,267	42,198
Total	228,372	54,605


	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

7.	Creditors within one year

	2022	2021
	£	£
Trade creditors / trade payables	517,128	5,562
Taxation and social security	5,725	55,399
Other creditors	226	963
Accrued liabilities and deferred income	1,947	1,729
Total	525,026	63,653


	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.